- Home
- >
- Japan
- >
- Regulatory Affairs
Regulatory Affairs Consulting for Life Sciences in Japan
Expert Regulatory Affairs Consulting for Life Sciences Industries in Japan, Supporting Market Entry and Compliance

Services We Offer
Regulatory Affairs Services in Japan
At Artixio, we assist life sciences businesses in meeting Japan’s regulatory requirements. From product development to post-market support, our team works closely with you to ensure your products comply with local regulations.
We aim to make the approval process clear and efficient, helping your products reach the market confidently. With our expertise, you’ll receive guidance throughout the process, giving you the support you need to succeed in Japan.
Industry | Regulatory Body |
---|---|
Pharmaceuticals & Medical Devices | Pharmaceuticals and Medical Devices Agency (PMDA) Ministry of Health, Labour, and Welfare (MHLW) |
Cosmetics | Ministry of Health, Labour, and Welfare (MHLW) |
Nutrition Products | Consumer Affairs Agency (CAA) |
Veterinary Products | Animal Health and Food Safety Department (MHLW) |
Regulatory Affairs Lifecycle in Japan

Gather all necessary documents and data (clinical trials, product details, etc.) for submission.

Submit the required information to the appropriate regulatory authority (e.g., PMDA, MHLW).

The regulatory authority assesses your product's safety, effectiveness, and compliance with local standards.

Monitor the product's performance and safety once it’s on the market.

Regularly review and update approvals to maintain ongoing market access and compliance.
Why Artixio for Japan’s regulatory affairs
- We understand Japan’s unique regulatory environment and help you stay compliant.
- Our team works closely with the PMDA and MHLW to handle all the regulatory processes.
- With years of experience in Japan, we know the ins and outs of local requirements.
- We’ve successfully guided numerous products through Japan’s approval process.
- From initial submission to market launch, we’re here to support you every step of the way.
FAQs
What are the main regulatory bodies in Japan?
The Pharmaceuticals and Medical Devices Agency (PMDA) and the Ministry of Health, Labour, and Welfare (MHLW) are the key authorities responsible for product approvals in Japan. For other products, such as food and cosmetics, the Consumer Affairs Agency (CAA) plays an important role.
What are the main requirements for submitting a product for approval in Japan?
You will need to submit a variety of documentation, including clinical data, safety profiles, manufacturing details, and product labeling, depending on the product type. It’s important to ensure that all documents meet Japanese standards.
What happens after my product is approved in Japan?
Once approved, your product will be registered, and you can begin market distribution. However, ongoing post-market surveillance and reporting are required to monitor product safety and effectiveness.
Are there any specific post-market requirements in Japan?
Yes, post-market surveillance is mandatory in Japan, and products must undergo periodic inspections and adverse event reporting. Continuous monitoring is essential to maintain compliance.
Still Have Questions ?
Get expert answers tailored to your needs.
Industries We Serve in the Japan
Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy

Medical & Technical Writing

Publishing & Submission

Product Registration

Investigation New Drug Application (IND)

New Drug Application (NDA)

Post Approval Lifecycle Maintenance

Artwork and Label Review

Ad Promo Review
Regulatory Affairs Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea
Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in
Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...
May 2, 2025

UK Releases Amendment &
In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...
April 23, 2025

Artixio Announces Grant for
HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...
April 16, 2025